{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:35:52Z","timestamp":1773977752945,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["R18FD005292"],"award-info":[{"award-number":["R18FD005292"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1177\/2168479017720247","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:42:21Z","timestamp":1501152141000},"page":"206-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials"],"prefix":"10.1007","volume":"52","author":[{"given":"Diane","family":"Bloom","sequence":"first","affiliation":[]},{"given":"Joel","family":"Beetsch","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Harker","sequence":"additional","affiliation":[]},{"given":"Sharon","family":"Hesterlee","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Bray","family":"Patrick-Lake","sequence":"additional","affiliation":[]},{"given":"Wendy","family":"Selig","sequence":"additional","affiliation":[]},{"given":"Jeffrey","family":"Sherman","sequence":"additional","affiliation":[]},{"given":"Sophia K.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"James E.","family":"Valentine","sequence":"additional","affiliation":[]},{"given":"Jamie N.","family":"Roberts","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,12,30]]},"reference":[{"key":"5202206_CR1","unstructured":"US Food and Drug Administration. Patient-focused drug development. http:\/\/www.fda.gov\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/ucm347317.htm. Accessed June 17, 2015."},{"key":"5202206_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1037\/0033-2909.131.6.856","volume":"131","author":"D Albarracin","year":"2005","unstructured":"Albarracin D, Gillette JC, Earl AN, Glasman LR, Durantini MR, Ho MH. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull. 2005;131:856\u2013897.","journal-title":"Psychol Bull"},{"key":"5202206_CR3","doi-asserted-by":"crossref","unstructured":"Parsons S, Starling B, Mullan-Jensen C, Tham S-G, Warner K, Wever K. What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries. BMJ Open. 2015;5.","DOI":"10.1136\/bmjopen-2014-006420"},{"key":"5202206_CR4","unstructured":"Pushparajah DS, Geissler J, Westergaard N. EUPATI: collaboration between patients, academia and industry to champion the informed patient in the research and development of medicines. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwifr5TQkZjUAhXGKCYKHaBjA1UQFggkMAA&url=https%3A%2F%2Fwww.eupati.eu%2Fwp-content%2Fuploads%2F2016%2F09%2F2015-07-Journal-Med-Dev-Sciences-EUPATI-Collaboration-between-patients-academia-industry_EN.pdf&usg=AFQjCNGlYRt2IlhBs758wOmeL-N5974yYg&sig2=hIwnuY4eKDavpzP0ncA7kg&cad=rja. Accessed May 30, 2017."},{"key":"5202206_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/2168479015580384","volume":"49","author":"A Hoos","year":"2015","unstructured":"Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines. Therapeutic Innovation & Regulatory Science. 2015;49:929\u2013939.","journal-title":"Therapeutic Innovation & Regulatory Science"},{"key":"5202206_CR6","unstructured":"Pavitt S. EUPATI: an initiative to provide expertise in patient advocacy and in medicines development processes. https:\/\/www.eupati.eu\/wp-content\/uploads\/2016\/09\/2013-09-Regulatory-Rapporteur-September-EUPATI_EN.pdf. Accessed May 30, 2017."},{"key":"5202206_CR7","unstructured":"Clinical Trials Transformation Initiative. CTTI Membership. https:\/\/www.ctti-clinicaltrials.org\/membership. Accessed November 3, 2016."},{"key":"5202206_CR8","doi-asserted-by":"publisher","first-page":"e0140232","DOI":"10.1371\/journal.pone.0140232","volume":"10","author":"SK Smith","year":"2015","unstructured":"Smith SK, Selig W, Harker M, et al. Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey. PLoS One. 2015;10:e0140232.","journal-title":"PLoS One"},{"key":"5202206_CR9","unstructured":"Clinical Trials Transformation Initiative. Patient groups and clinical trials. Meeting materials. http:\/\/www.ctti-clinicaltrials.org\/what-we-do\/ctti-projects\/patient-groups\/expert-meeting. Accessed November 2, 2016."},{"key":"5202206_CR10","unstructured":"Clinical Trials Transformation Initiative. Effective engagement with patient groups around clinical trials. Overview and deliverables. http:\/\/www.ctti-clinicaltrials.org\/what-we-do\/projects\/patient-groups\/products. Accessed November 2, 2016."},{"key":"5202206_CR11","unstructured":"Clinical Trials Transformation Initiative. CTTI recommendations: effective engagement with patient groups around clinical trials. Recommendations document. https:\/\/www.ctti-clinicaltrials.org\/files\/pgctrecs.pdf. Accessed March 28, 2016."},{"key":"5202206_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/2168479015622668","volume":"50","author":"G Borup","year":"2016","unstructured":"Borup G, Bach KF, Schmiegelow M, Wallach-Kildemoes H, Bjerrum OJ, Westergaard N. A paradigm shift towards patient involvement in medicines development and regulatory science. Therapeutic Innovation & Regulatory Science. 2016;50:304\u2013311.","journal-title":"Therapeutic Innovation & Regulatory Science"},{"key":"5202206_CR13","doi-asserted-by":"publisher","first-page":"e008928","DOI":"10.1136\/bmjopen-2015-008928","volume":"6","author":"S Parsons","year":"2016","unstructured":"Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, Wever K. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study. BMJ Open. 2016;6:e008928.","journal-title":"BMJ Open"},{"key":"5202206_CR14","unstructured":"Levitan B, Getz K, Eisenstein E, et al. Assessing the financial value of patient engagement: a quantitative approach from CTTI\u2019s Patient Groups and Clinical Trials project. Therapeutic Innovation & Regulatory Science. In press."},{"key":"5202206_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","volume":"374","author":"I Chalmers","year":"2009","unstructured":"Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86\u201389.","journal-title":"Lancet"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479017720247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2168479017720247","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1177\/2168479017720247\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2168479017720247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479017720247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T13:05:10Z","timestamp":1598015110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1177\/2168479017720247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["5202206"],"URL":"https:\/\/doi.org\/10.1177\/2168479017720247","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}